PBD Podcast Ed Dowd On Pfizer Increasing Their Revenue to $90B After Covid-19 | Ep. 244 | Part 1
Mar 7, 2023
Ed Dowd, a former BlackRock money manager and author of "Cause Unknown," dives into the staggering rise of Pfizer's revenues to $90 billion post-COVID-19. He scrutinizes alarming trends in young mortality rates and the demographics of vaccine recipients. The conversation raises ethical questions around vaccine mandates, particularly in schools, and examines skepticism surrounding the rapid rollout of the COVID-19 vaccine amid accusations of corporate greed. Dowd’s insights challenge the mainstream narrative and unveil troubling implications for public health.
AI Snips
Chapters
Books
Transcript
Episode notes
Ed Dowd's BlackRock Background
- Ed Dowd previously managed funds at BlackRock, growing them substantially.
- He left BlackRock before their heavy involvement in ESG.
Pattern Recognition in Frauds
- Dowd identifies recurring patterns in financial frauds, like the "new paradigm" claim during the dot-com bubble.
- He uses pattern recognition and trend analysis to anticipate market shifts.
Unified Government Response
- Dowd notes the unusual global government unison in messaging and procedures around COVID-19.
- This unified response, never seen before, was a clue that something unusual was occurring.
